Core Viewpoint - The company has signed significant business cooperation agreements with Peking University Sixth Hospital and Shandong Provincial Mental Health Center to advance the research and commercialization of digital therapies for mental health [1][4]. Group 1: Collaboration Details - The collaboration with Peking University Sixth Hospital includes the development of digital therapies and clinical application research, focusing on ADHD cognitive digital therapy effectiveness and a precision intelligent diagnosis system for depression [2]. - The research scope encompasses developing digital therapy products for emotional and behavioral issues across the entire lifecycle, including clinical validation of cognitive digital therapies aimed at improving learning abilities in children with ADHD [2]. - The partnership with Shandong Provincial Mental Health Center involves developing cognitive screening and intervention systems for mental disorders, as well as methods for capacity training guided by virtual humans [3]. Group 2: Laboratory Establishment - The "Precision Intelligent Diagnosis and Innovation Transformation Key Laboratory for Mental Diseases" has been officially approved, with the company as a core co-construction unit alongside Peking University Sixth Hospital and the National Engineering Research Center for Software Engineering [3]. - The laboratory will focus on innovation and transformation driven by clinical needs in mental health, integrating clinical medicine, basic research, technology development, and hardware innovation [3]. Group 3: Strategic Positioning - The company has established close commercial cooperation with Beijing Anding Hospital, a top-tier mental health facility, to promote the clinical application of digital mental health therapies [4]. - The recent collaborations expand the company's network across key mental health hospitals in China, creating a comprehensive commercial landing network from national flagship centers to regional hubs and specialized hospitals [4]. - The board believes that the implementation of these cooperation agreements and the approval of the key laboratory will strengthen the company's pioneering advantage in the digital mental health therapy field, accelerating product development and commercialization [4].

Core Viewpoint - The company has signed significant business cooperation agreements with Beijing University Sixth Hospital and Shandong Provincial Mental Health Center to advance the research and commercialization of digital therapies for mental health [1][4]. Group 1: Collaboration Details - The collaboration with Beijing University Sixth Hospital includes the development of digital therapies and clinical application research, focusing on attention deficit hyperactivity disorder (ADHD) cognitive digital therapy and a precision intelligent diagnosis system for depression [2]. - The research scope encompasses the development of digital therapy products for emotional and behavioral issues across the entire lifecycle, including clinical validation of cognitive digital therapies aimed at improving learning abilities in children with ADHD [2]. - The partnership with Shandong Provincial Mental Health Center involves the development of cognitive screening and intervention systems for mental disorders, as well as methods for capacity training guided by virtual humans [3]. Group 2: Laboratory Establishment - The "Precision Intelligent Diagnosis and Innovation Transformation Key Laboratory for Mental Diseases" has been officially approved, with the company as a core co-construction unit alongside Beijing University Sixth Hospital and the National Engineering Research Center for Software Engineering [3]. - The laboratory will focus on innovation and transformation driven by clinical needs in mental health, integrating clinical medicine, basic research, technology development, and hardware innovation [3]. Group 3: Strategic Positioning - The company has established close commercial cooperation with Beijing Anding Hospital, a top-tier mental health facility, to promote the clinical application of digital mental health therapies [4]. - The recent collaborations further expand the company's network within core mental health specialty hospitals across the country, creating a comprehensive commercial landing network from national flagship centers to regional hubs and key specialty hospitals [4]. - The board believes that the implementation of these cooperation agreements and the approval of the key laboratory will strengthen the company's first-mover advantage in the digital mental health therapy sector, accelerating product development and commercialization processes [4].

Core Viewpoint - The company has signed significant business cooperation agreements with Beijing University Sixth Hospital and Shandong Provincial Mental Health Center to advance the research and commercialization of digital therapies for mental health [1][2][3]. Group 1: Joint Research Content - The research will focus on developing digital therapies and clinical applications, including the effectiveness of cognitive digital therapies for Attention Deficit Hyperactivity Disorder (ADHD) and a precision intelligent diagnosis system for depression [2]. - The research scope includes developing digital therapy products for emotional and behavioral issues across the entire lifecycle, with clinical validation for various age groups [2][3]. Group 2: Commercial Cooperation Content - The company will collaborate on digital technology services for cognitive disorder diagnosis and treatment, establishing a health management system covering elderly, children, and adults [2][3]. Group 3: Establishment of Key Laboratory - The "Beijing Key Laboratory for Precision Intelligent Diagnosis and Transformation of Mental Disorders" has been officially approved, with the company as a core co-builder [4]. - The laboratory will focus on innovation and transformation driven by clinical needs, integrating clinical medicine, basic research, technology development, and hardware innovation [4]. Group 4: Strategic Importance - The board believes that the implementation of these cooperation agreements and the approval of the key laboratory will strengthen the company's pioneering advantage in the field of digital mental health therapies, accelerating product development and commercialization [5]. - The company aims to continue partnerships with top medical institutions to build a nationwide integrated digital mental health service system [5].

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性 或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部分內容而產生或因倚 賴該等內容而引致的任何損失承擔任何責任。 BrainAurora Medical Technology Limited 腦動極光醫療科技有限公司 及 獲批精神疾病精準智能診療創新轉化北京市重點實驗室 本公告為腦動極光醫療科技有限公司（「本公司」，連同其附屬公司統稱「本集團」） 自願發佈的公告，目的是使廣大投資者了解本集團最新業務發展情況。 本公司董事會（「董事會」）欣然宣佈，本公司近期與北京大學第六醫院及山東省 精神衛生中心（統稱「合作方」）分別簽訂重要業務合作協議（統稱「業務合作協 議」），共同推進精神健康數字療法產品的研發與商業化。此外，本公司與北京大 學第六醫院、北京大學軟件工程國家工程研究中心聯合申報的「精神疾病精準智 能診療創新轉化北京市重點實驗室」（「實驗室」）已正式獲准組建。 一、與北京大學第六醫院簽訂業務合作協議 1. 聯合研發內容 （於開曼群島註冊成立的有限公司） （股份代號：6681） 自願公告 簽訂重要業務合作協議 研究內 ...

Core Viewpoint - The "Second Mental Health Integration and Innovation Conference" held in Wuhan focused on the development and innovation in the mental health field, emphasizing the importance of digital therapies and collaborative efforts among various stakeholders [1][2][11] Group 1: Conference Overview - The conference was organized by JD Health, with participation from over a hundred experts from various medical institutions and pharmaceutical companies, discussing the future paths and innovative practices in mental health [1][2] - A key initiative launched during the conference was the development of the "Clinical Application Guidelines for Digital Mental Health Therapies," aimed at providing a scientific framework for the application of digital therapies [6][11] Group 2: Key Discussions - Discussions highlighted the need for integrating social resources and utilizing digital platforms to create a collaborative network for mental health services, moving away from isolated hospital practices [4][6] - Experts emphasized the importance of a new paradigm for youth mental health interventions, advocating for collaboration among medical, educational, and familial sectors to enhance service efficiency [4][5] Group 3: JD Health's Role - JD Health has positioned itself as a connector of professional resources in the mental health sector, focusing on integrating specialized services with public needs [8] - The company has invested in AI and digital therapies, collaborating with top hospitals to develop systems for early risk screening and comprehensive management of mental health services [8][9] Group 4: Pharmaceutical Accessibility - JD Health has established deep partnerships with numerous pharmaceutical companies, offering over 500 types of mental health medications, ensuring broad coverage and rapid delivery through its logistics network [9] - The company prioritizes medication safety by employing a large team of pharmacists to provide 24/7 consultation and strict oversight on high-risk medications [9] Group 5: Future Directions - The conference underscored the importance of cross-disciplinary collaboration and the integration of digital technologies in advancing mental health services in China, aiming for a more efficient and accessible system for public mental health [11]